<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02775838</url>
  </required_header>
  <id_info>
    <org_study_id>SPY-Kidney</org_study_id>
    <nct_id>NCT02775838</nct_id>
  </id_info>
  <brief_title>Measurements of Kidney Perfusion After Transplantation by Intraoperative Fluorescence Angiography</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Erlangen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universit√§tsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Erlangen</source>
  <brief_summary>
    <textblock>
      Aim of this clinical study is to establish a novel technique, the so called intraoperative
      fluorescence angiography, for kidney graft perfusion visualization during the transplant
      procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Additional to the common transplant procedure, measurements of the graft perfusion should be
      established in two ways. Firstly, each kidney should be measured by a common duplex
      ultrasound measurement to assess the resistance index (RI) in the three poles of the kidney
      (upper, middle, lower pole). Secondly, intraoperative fluorescence angiography is going to be
      performed. Therefore, the camera of the fluorescence angiography system (SPY Elite System,
      Novadaq, USA) is positioned over the organ, and the fluorescence dye (ICG) is applicated
      intravenously. The aim will be to correlate the fluorescence angiography findings with the
      RIs and therefore to establish valuable fluorescence parameters.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2016</start_date>
  <completion_date type="Actual">January 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 1, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of intraoperative SPY Perfusion Parameters with short-term outcome of the graft function</measure>
    <time_frame>24 Months</time_frame>
    <description>The intraoperative fluorescence parameters (Ingress, Ingressrate, Egress, Egressrate) will be correlated with the creatinine level of the first 10 postoperative days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the ideal ICG dosage for intraoperative kidney perfusion</measure>
    <time_frame>6 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of intraoperative measured resistance indices with fluorescence parameters (Ingress, Ingressrate, Egress, Egressrate)</measure>
    <time_frame>12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of graft rejection episodes and fluorescence parameters</measure>
    <time_frame>24 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of fluorescence parameters with numbers of dialysis needed during the first 10 postoperative days</measure>
    <time_frame>24 Months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Correlation of intraoperative fluorescence parameters of the ureter with ureter anastomosis complications postoperatively</measure>
    <time_frame>24 Months</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Kidney Transplantation</condition>
  <arm_group>
    <arm_group_label>kidney transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous injection of Indocyanine Green in patients receiving kidney transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indocyanine green</intervention_name>
    <description>perioperative application of Indocyanine green (ICG)</description>
    <arm_group_label>kidney transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients receiving kidney transplantation

          -  Deceased donor and living donor transplantations

        Exclusion Criteria:

          -  Allergy against indocyanine green

          -  Iodine allergy

          -  Contrast allergy

          -  Penicillin allergy

          -  Allergic diathesis

          -  Liver insufficiency

          -  Pregnancy

          -  Hyperthyreosis

          -  Pulmonary arterial hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich Rother, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Erlangen, Vascular Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kai Nowak, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Mannheim, General Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Erlangen, Vascular Surgery</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Mannheim, General Surgery</name>
      <address>
        <city>Mannheim</city>
        <zip>68159</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 13, 2016</study_first_submitted>
  <study_first_submitted_qc>May 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 18, 2016</study_first_posted>
  <last_update_submitted>May 6, 2020</last_update_submitted>
  <last_update_submitted_qc>May 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Erlangen</investigator_affiliation>
    <investigator_full_name>Ulrich Rother</investigator_full_name>
    <investigator_title>Dr. med. Ulrich Rother</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

